文献速递膀胱癌与上尿路尿路上皮癌

经尿道膀胱肿瘤电切术围手术期并发症:质量改进启示

The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement.
PubMed 文献 · Urology · 2018-10-23

该研究基于美国国家手术质量改进计划数据库2010至2015年24100例接受经尿道膀胱肿瘤电切术的患者,评估30天围手术期结局。结果显示并发症发生率5.1%,再入院3.7%,死亡0.8%,肿瘤大小是唯一与所有围手术期终点独立相关的因素。

要点

  • TURBT术后30天并发症发生率为5.1%,再入院率为3.7%。
  • 再入院最常见原因为出血(29%)和感染(21%)。
  • 较大肿瘤尺寸与所有围手术期终点风险增加独立相关。

核心结论

  • TURBT围手术期并发症发生率较高,是质量改进的重要目标。
  • 肿瘤大小、患者功能状态和特定合并症与围手术期并发症和死亡风险增加独立相关。

研究设计与样本

  • 回顾性队列研究,纳入美国国家手术质量改进计划数据库中2010至2015年24100例18至89岁接受TURBT的患者。
  • 采用多因素logistic回归分析患者特征和肿瘤大小(小于2厘米、2至5厘米、大于5厘米)与30天围手术期结局的关联。

主要发现

  • 30天术后并发症发生率为5.1%,围手术期输血率为1.5%,再入院率为3.7%,再手术率为1.5%,死亡率为0.8%。
  • 再入院最常见原因为出血(29%)和感染(21%)。
  • 多因素分析中,充血性心力衰竭、肾衰竭、较高的美国麻醉医师协会分级和依赖功能状态与围手术期并发症增加相关。
  • 仅较大肿瘤尺寸与所有围手术期终点风险增加独立相关。

临床怎么用

  • 可用于患者咨询,告知TURBT围手术期并发症、再入院和死亡风险。
  • 围手术期管理应关注出血和感染并发症的预防与监测。
  • 质量改进项目可针对肿瘤大小、患者功能状态和合并症进行风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize the perioperative morbidity of transurethral resection of bladder tumor (TURBT) in order to identify important determinants of both quality and cost in the delivery bladder cancer care. METHODS: We identified 24,100 patients aged 18-89 years who underwent TURBT from 2010 to 2015 in the National Surgical Quality Improvement Program database. Multivariable logistic regression was performed to evaluate the associations of patient features and tumor size (<2 cm, 2-5 cm, or >5 cm) with 30-day perioperative outcomes. RESULTS: Thirty-day postoperative complications occurred in 5.1% of patients, perioperative blood transfusion in 1.5% of patients, hospital readmission in 3.7% of patients, reoperation in 1.5% of patients, and mortality in 0.8% of patients. The most common reasons for readmission were bleeding (29%) and infectious (21%) complications. Although several patient features were associated with increased perioperative morbidity on multivariable analysis, including congestive heart failure, renal failure, higher American Society of Anesthesiology class, and dependent functional status, only larger tumor size was independently associated with increased risks of all perioperative endpoints. CONCLUSION: Perioperative morbidity following TURBT is substantial and represents an important target for quality improvement. Extent of resection, patient functional status, and specific comorbidities are independently associated with increased risks of perioperative morbidity and mortality. These results have implications for patient counseling, perioperative management, and quality improvement programs.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Pereira JF, Pareek G, Mueller-Leonhard C, et al. The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement. Urology. 2018. PMID: 30366045. doi:10.1016/j.urology.2018.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。